课题基金 / 基金详情

SAFETY AND EFFICACY OF TROGLITAZONE IN POLYCYSTIC OVARIAN SYNDROME

SAFETY AND EFFICACY OF TROGLITAZONE IN POLYCYSTIC OVARIAN SYNDROME
曲格列酮治疗多囊卵巢综合征的安全性和有效性
批准号：
6218070
负责人：
WILLIAM R MEYER
金额：
$0.02万
依托单位：
UNIV OF NORTH CAROLINA CHAPEL HILL
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6218070
关键词：
adrenal disorder amenorrhea androgens clinical research drug screening /evaluation hirsutism human subject human therapy evaluation ovulation pituitary disorders polycystic ovary syndrome reproductive system disorder chemotherapy troglitazone

项目摘要

项目成果

WILLIAM R MEYER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To determine the safety and efficacy of Troglitazone in improving the manifestations of polycystic ovarian syndrome including oligo/anovulation, oligo/amenorrhea, hyperandrogenism, and hirsutism.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SAFETY AND EFFICACY OF TROGLITAZONE IN POLYCYSTIC OVARIAN SYNDROME
SAFETY AND EFFICACY OF TROGLITAZONE IN POLYCYSTIC OVARIAN SYNDROME
SAFETY AND EFFICACY OF TROGLITAZONE IN POLYCYSTIC OVARIAN SYNDROME
SAFETY AND EFFICACY OF TROGLITAZONE IN POLYCYSTIC OVARIAN SYNDROME
海外基金